# INFUSE® Bone Graft and MASTERGRAFT® Granules With CD HORIZON® for Posterolateral Lumbar Fusion in Patients With Degenerative Disc Disease - Pilot Study

> **NCT01491542** · NA · COMPLETED · sponsor: **Medtronic Spinal and Biologics** · enrollment: 46 (actual)

## Conditions studied

- Degenerative Disc Disease

## Interventions

- **DEVICE:** INFUSE® Bone Graft/MASTERGRAFT® Granules/CD HORIZON®
- **DEVICE:** Autogenous Bone / CD HORIZON® Spinal System

## Key facts

- **NCT ID:** NCT01491542
- **Lead sponsor:** Medtronic Spinal and Biologics
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** 2006-11
- **Final completion:** 2007-03
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2023-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01491542

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01491542, "INFUSE® Bone Graft and MASTERGRAFT® Granules With CD HORIZON® for Posterolateral Lumbar Fusion in Patients With Degenerative Disc Disease - Pilot Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01491542. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*